substance p has been researched along with Osteoporosis, Postmenopausal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H; Liu, X; Wang, C; Xiong, Y; Yang, L; Zhang, R; Zhu, X | 1 |
| Chen, J; Li, Z; Liu, Y; Wang, B; Wang, X; Xiao, J; Yu, W | 1 |
2 other study(ies) available for substance p and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Postmenopausal osteoporosis is associated with the regulation of SP, CGRP, VIP, and NPY.
Topics: Animals; Brain; Calcitonin Gene-Related Peptide; Calcitonin Receptor-Like Protein; Female; Humans; Neuropeptide Y; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Vasoactive Intestinal Peptide | 2018 |
Correlation between neuropeptide distribution, cancellous bone microstructure and joint pain in postmenopausal women with osteoarthritis and osteoporosis.
Topics: Aged; Arthralgia; Calcitonin Gene-Related Peptide; Cancellous Bone; Female; Humans; Middle Aged; Neuropeptide Y; Neuropeptides; Osteoarthritis; Osteoporosis, Postmenopausal; Pain Measurement; Pain Perception; Postmenopause; Substance P; Vasoactive Intestinal Peptide | 2016 |